Martin Javier San, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 34,458 shares at $28.73 ($991K) on 2023-11-20, disclosed to the SEC on 2023-11-22.
Scheduled sale ($991k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.73 | 14,758 | $424K | 42.8% |
| 2 | $28.73 | 14,758 | $424K | 42.8% |
| 3 | $29.00 | 4,942 | $143K | 14.5% |
| Total | $28.77 avg | 34,458 | $991K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $3K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $6K | — | Filing → |
| ARWR | SELL | 2024-01-08 | $450K | — | Filing → |